EFG Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Sell |
76,257
-4,102
| -5% | -$136K | 0.36% | 123 |
|
|
2025
Q1 | $3.23M | Sell |
80,359
-3,503
| -4% | -$141K | 0.54% | 63 |
|
|
2024
Q4 | $3.94M | Buy |
83,862
+49,628
| +145% | +$2.33M | 0.54% | 62 |
|
|
2024
Q3 | $1.81M | Buy |
34,234
+2,468
| +8% | +$130K | 0.3% | 147 |
|
|
2024
Q2 | $1.72M | Buy |
31,766
+150
| +0.5% | +$8.12K | 0.3% | 134 |
|
|
2024
Q1 | $2.22M | Sell |
31,616
-602
| -2% | -$42.2K | 0.38% | 105 |
|
|
2023
Q4 | $2.69M | Sell |
32,218
-3,485
| -10% | -$291K | 0.51% | 72 |
|
|
2023
Q3 | $1.05M | Sell |
35,703
-3,409
| -9% | -$100K | 0.25% | 139 |
|
|
2023
Q2 | $1.28M | Sell |
39,112
-2,314
| -6% | -$75.4K | 0.27% | 125 |
|
|
2023
Q1 | $1.46M | Sell |
41,426
-2,320
| -5% | -$81.6K | 0.32% | 110 |
|
|
2022
Q4 | $2M | Buy |
43,746
+12,897
| +42% | +$589K | 0.45% | 77 |
|
|
2022
Q3 | $1.49M | Sell |
30,849
-2,321
| -7% | -$112K | 0.35% | 105 |
|
|
2022
Q2 | $1.3M | Sell |
33,170
-2,846
| -8% | -$112K | 0.27% | 116 |
|
|
2022
Q1 | $1.33M | Sell |
36,016
-471
| -1% | -$17.3K | 0.2% | 148 |
|
|
2021
Q4 | $1.66M | Buy |
+36,487
| New | +$1.66M | 0.22% | 134 |
|